Pfizer Vaccine: Allergic Reactions in UK Prompt Warning
People with a “significant history” of allergic reactions shouldn’t receive the new Pfizer-BioNTech vaccine pending an investigation of two adverse reactions reported on the first day of the U.K.’s mass vaccination program, British health officials said Wednesday.
Pfizer’s vaccine candidate is seeking emergency use approval from the U.S. Food and Drug Administration, and experts say no significant issues emerged in U.S. testing.
Read Also: 5 Ways Data Cloud Can Help Life Sciences Become Data-Driven
[the_ad id=”10542″]
“That’s why it’s really puzzling me,” said Dr. Peter Hotez, a pediatrician and dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston.
Stephen Powis, national medical director for the National Health Service in England, said both affected patients there were “recovering well” and that the directive came “on a precautionary basis.”
Vaccines are urgently needed in the U.S., where more than 2,500 deaths and over 215,000 new coronavirus cases were reported Tuesday alone. The nation soared beyond 15 million total infections this week with no indication the latest surge is ebbing.
[the_ad id=”10542″]
SOURCE
Author: John Bacon and Elinor Aspegren
Publication: USA Today
Title: Coronavirus updates: Allergic reactions in UK prompt warning; stimulus talks coming down to wire; Canada approves Pfizer vaccine
